Literature DB >> 14656346

Mechanisms of severe asthma.

S Wenzel1.   

Abstract

The mechanisms behind the development of severe asthma are poorly understood. However, these patients disproportionately consume healthcare resources related to asthma. Severe asthma may develop over time, or may develop shortly after onset of the disease. The genetic and environmental elements that may be most important in the development of severe disease are poorly understood. Physiologically, these patients often have air trapping and airway collapsibility. The pathology demonstrates a heterogeneity of findings, including continued eosinophilic inflammation, an apparently different pathology, structural changes likely to be remodelling related, and predominant distal disease. Treatment remains problematic and likely will remain so until a better understanding of this disease develops.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656346     DOI: 10.1111/j.1365-2222.2003.01799.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  14 in total

1.  Asthma severity and exposure to occupational asthmogens.

Authors:  Nicole Le Moual; Valérie Siroux; Isabelle Pin; Francine Kauffmann; Susan M Kennedy
Journal:  Am J Respir Crit Care Med       Date:  2005-06-16       Impact factor: 21.405

Review 2.  Severe asthma: an expanding and mounting clinical challenge.

Authors:  Matthew C Bell; William W Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2013-02-26

Review 3.  The microbiome in asthma.

Authors:  Magali Noval Rivas; Timothy R Crother; Moshe Arditi
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

Review 4.  Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.

Authors:  Pio Conti; Francesco Carinci; Gianfranco Lessiani; Enrico Spinas; Spyridon K Kritas; Gianpaolo Ronconi; Alessandro Caraffa; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

5.  Notch ligand delta-like 4 regulates development and pathogenesis of allergic airway responses by modulating IL-2 production and Th2 immunity.

Authors:  Sihyug Jang; Matthew Schaller; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

6.  A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

Authors:  Karl Ziegelbauer; Florian Gantner; Nicholas W Lukacs; Aaron Berlin; Kinji Fuchikami; Toshiro Niki; Katsuya Sakai; Hisayo Inbe; Keisuke Takeshita; Mina Ishimori; Hiroshi Komura; Toshiki Murata; Timothy Lowinger; Kevin B Bacon
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

7.  TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells.

Authors:  Arij Faksh; Rodney D Britt; Elizabeth R Vogel; Michael A Thompson; Hitesh C Pandya; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

8.  Asthma and Chronic Obstructive Pulmonary Disease (COPD) - Differences and Similarities.

Authors:  Vesna Cukic; Vladimir Lovre; Dejan Dragisic; Aida Ustamujic
Journal:  Mater Sociomed       Date:  2012

9.  Rhinovirus-Infected Epithelial Cells Produce More IL-8 and RANTES Compared With Other Respiratory Viruses.

Authors:  Yoon Hong Chun; Ju Young Park; Huisu Lee; Hyun Sook Kim; Sulmui Won; Hyun Jung Joe; Woo Jin Chung; Jong-Seo Yoon; Hyun Hee Kim; Jin Tack Kim; Joon Sung Lee
Journal:  Allergy Asthma Immunol Res       Date:  2013-05-27       Impact factor: 5.764

10.  Incidence and risk factors for exacerbations of asthma during pregnancy.

Authors:  Zarqa Ali; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.